0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry]

RxCUI: 2640400
RxNorm name: 0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry]
Display name: 0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry]
Full name: 0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761216	Yusimry	adalimumab-aqvh	351(k) Biosimilar	Rx	2026-06-01

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
4cab600d-6950-409f-a6d8-d447da22cd95	0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry]	SBD	6	These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee	20251031
4cab600d-6950-409f-a6d8-d447da22cd95	Yusimry 40 MG per 0.8 ML Auto-Injector	SY	6	These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee	20251031
4cab600d-6950-409f-a6d8-d447da22cd95	YUSIMRY 40 MG in 0.8 ML Auto-Injector	PSN	6	These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee	20251031
4cab600d-6950-409f-a6d8-d447da22cd95	0.8 ML Yusimry 50 MG/ML Auto-Injector	SY	6	These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee	20251031
cd0e7af2-7704-49ce-bde9-f645294b6788	0.8 ML adalimumab-aqvh 50 MG/ML Auto-Injector [Yusimry]	SBD	6	These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee	20250516
cd0e7af2-7704-49ce-bde9-f645294b6788	Yusimry 40 MG per 0.8 ML Auto-Injector	SY	6	These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee	20250516
cd0e7af2-7704-49ce-bde9-f645294b6788	0.8 ML Yusimry 50 MG/ML Auto-Injector	SY	6	These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee	20250516
cd0e7af2-7704-49ce-bde9-f645294b6788	YUSIMRY 40 MG in 0.8 ML Auto-Injector	PSN	6	These highlights do not include all the information needed to use YUSIMRY safely and effectively. See full prescribing information for YUSIMRY. YUSIMRY (adalimumab-aqvh) injection, for subcutaneous use Initial U.S. Approval: 2021 YUSIMRY (adalimumab-aqvh) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences betwee	20250516